First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2013-06-06 17:04:05Open Document File Size: 148,49 KBShare Result on FacebookCompanyAppeal Chambres / AstraZeneca AB / ASTRA ZENECA AB / APPEAL OF THE EUROPEAN PATENT OFFICE CHAMBRES DE RECOURS / BESCHWERDEKAMMERN / Appeal 3 / Teva Pharmaceutical Industries Ltd. / /IndustryTermpharmaceutical formulations / treatment of resistant breast cancer / treatment of a patient with breast cancer / /MedicalConditioncancer / disease / breast cancer / Endocrine-Related Cancer / /OrganizationEuropean Patent Office / Opposition Division / EPC / Technical Board of Appeal / European Patent Office Office / Environmental Protection Agency / /PersonMichael Lederer / Qing Lu / U. Oswald A. Lindner / /PositionRepresentative / Chairman / resistant breast cancer Patent Proprietor / /ProgrammingLanguageL / /ProvinceOrStateIllinois / /PublishedMediumBreast Cancer Research and Treatment / /Technologydetailed protocol / /SocialTag |